New Year Bumper Sale @ Rs. 1 X
Codimol CV Dry Syrup is a prescription drug, available for use as Syrup. Codimol CV Dry Syrup also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Codimol CV Dry Syrup. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Codimol CV Dry Syrup side effects, there are can be others also. These have been listed below. Normally, these side effects of Codimol CV Dry Syrup are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Codimol CV Dry Syrup's effect is Mild during pregnancy and Moderate for lactating mothers. Warnings related to Codimol CV Dry Syrup's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Codimol CV Dry Syrup since this can cause severe adverse effects. Other contraindications of Codimol CV Dry Syrup have been discussed in the sections ahead.
Additionally, Codimol CV Dry Syrup may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Codimol CV Dry Syrup is considered safe while driving, and is addictive.
Codimol CV Dry Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Codimol CV Dry Syrup safe for pregnant women?
Pregnant women can consume [medicine]. Though Codimol Cv has mild side effects when taken during pregnany
Is the use of Codimol CV Dry Syrup safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Codimol Cv. Immediately discontinue Codimol Cv if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Codimol CV Dry Syrup on the Kidneys?
Codimol Cv may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Codimol CV Dry Syrup on the Liver?
Codimol Cv may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Codimol CV Dry Syrup on the Heart?
Very few cases of side effects of Codimol Cv on the heart have been reported.
Codimol CV Dry Syrup should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Codimol CV Dry Syrup unless your doctor advises you to do so -
Is this Codimol CV Dry Syrup habit forming or addictive?
Codimol CV Dry Syrup is not addictive in nature.
Interaction between Food and Codimol CV Dry Syrup
It is safe to take Codimol CV Dry Syrup with food.
Interaction between Alcohol and Codimol CV Dry Syrup
It is difficult to say anything about the effect of Codimol CV Dry Syrup and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311